Letter: Contact dermatitis associated with adriamycin (NSC-123127) and daunorubicin (NSC-82151).
D000328:Adult; D003630:Daunorubicin / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000139:chemically induced* / Q000473:pathology; D004317:Doxorubicin / Q000009:adverse effects*; D005453:Fluorescence; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000139:chemically induced
D004317:Doxorubicin; D003630:Daunorubicin